Regulatory compliance – Page 36

Record retention failures during system operation – CAPA and revalidation strategy

Managing Record Retention Failures During Operational Systems: A Strategic Playbook Failures in record retention during system operations can disrupt processes, hinder compliance, and potentially lead to regulatory sanctions. For pharmaceutical…

Inadequate worst-case selection during site expansion – CAPA and revalidation strategy

Addressing Inadequate Worst-Case Selection: A Playbook for Site Expansion CAPA and Revalidation In the fast-paced environment of pharmaceutical manufacturing, adequate planning and rigorous validation are essential, especially during site expansions.…

Record retention failures during system upgrade – inspection evidence requirements

Addressing Record Retention Failures During System Upgrades: An Inspection-Ready Playbook In the pharmaceutical industry, system upgrades are a critical part of maintaining compliance and operational efficiency. However, these transitions can…

Requalification overdue during change control – CAPA and revalidation strategy

Managing Requalification Delays Amid Change Control – A Pragmatic CAPA Approach The pharmaceutical industry continually faces challenges related to maintaining compliance with Good Manufacturing Practices (GMP) and meeting regulatory expectations.…

Electronic signatures misused during compliance audit – risk-based ERES remediation

Addressing the Misuse of Electronic Signatures During Compliance Audits: A Practical Playbook In the dynamic landscape of pharmaceutical manufacturing and quality compliance, the misuse of electronic signatures during audits poses…

CSV compliance weak during change control – risk-based validation alignment

Enhancing CSV Compliance During Change Control for Effective Risk-Based Validation In the fast-paced world of pharmaceutical manufacturing, maintaining compliance with Computer System Validation (CSV) during change control processes presents a…

Archival process non-compliant during study reconstruction – CAPA for GLP system gaps

Dealing with Archival Process Non-Compliance During Study Reconstruction: A Comprehensive CAPA Playbook In the realm of pharmaceutical manufacturing and laboratory practices, ensuring compliance with Good Laboratory Practices (GLP) is paramount,…

Record retention failures during system upgrade – preventing repeat Part 11 findings

Addressing Record Retention Failures During System Upgrades to Prevent Part 11 Findings In the ever-evolving landscape of pharmaceutical manufacturing, system upgrades can inadvertently lead to record retention failures, posing significant…

Change impact not assessed during system upgrades – CAPA and revalidation strategy

Assessing Change Impact During System Upgrades: A Comprehensive CAPA and Revalidation Playbook In the highly regulated pharmaceutical environment, staying compliant with GMP regulations is essential. However, system upgrades can often…

Record retention failures during validation lifecycle – preventing repeat Part 11 findings

Addressing Record Retention Issues During the Validation Lifecycle to Prevent Part 11 Findings Record retention failures represent a critical threat in pharmaceutical manufacturing, particularly during the validation lifecycle of Electronic…

Inadequate worst-case selection during inspection readiness – regulatory deficiency risk

Addressing Inadequate Worst-Case Selection During Inspection Readiness: A Practical Playbook In the pharmaceutical manufacturing landscape, the pressure of regulatory compliance and inspection readiness is ever-growing. One common shortfall observed during…

Hybrid paper-electronic workflows uncontrolled during compliance audit – CAPA and revalidation strategy

Strategies for Managing Uncontrolled Hybrid Paper-Electronic Workflows During Compliance Audits In the evolving landscape of pharmaceutical manufacturing, the integration of hybrid paper-electronic workflows has become a common practice. While these…